WallStreetZenWallStreetZen

NASDAQ: HRTX
Heron Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Heron Therapeutics earnings were -$13.6M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest HRTX earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$17.5M, up 634.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HRTX reported annual earnings of -$13.6M, with -87.7% growth. The next HRTX earnings date is Mar 4, 2026.

HRTX earnings history

Current Revenue
$155.1M
Current Earnings
-$13.6M
Current Profit Margin
-8.8%

HRTX Return on Equity

Current Company
N/A
Current Industry
-21.2%
Current Market
35.1%

HRTX Return on Assets

Current Company
-5.7%
Current Industry
-8.8%
HRTX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HRTX announces earnings.

HRTX Return on Capital Employed

Current Company
-6.97%
Current Industry
-3.5%
HRTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HRTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HRTX-$8.74M-$13.58MN/A-$0.08
MDWD-$15.43M-$20.60MN/A-$1.85
PALI-$11.10M-$11.23MN/A-$2.12
CABA-$145.48M-$158.52MN/A-$2.53
STTK-$50.69M-$54.90MN/A-$1.02
View Top Biotech Stocks

HRTX earnings dates

Next earnings date
Mar 4, 2026

Heron Therapeutics Earnings Reports & History FAQ

What were Heron Therapeutics's earnings last quarter?

On HRTX's earnings call on Invalid Date, Heron Therapeutics (NASDAQ: HRTX) reported Q3 2025 earnings per share (EPS) of -$0.10, up 233.33% year over year. Total HRTX earnings for the quarter were -$17.50 million. In the same quarter last year, Heron Therapeutics's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Heron Therapeutics stock.

When does Heron Therapeutics report earnings?

The next HRTX earnings call is Invalid Date. Add HRTX to your watchlist to be reminded of Heron Therapeutics's next earnings date.

Is Heron Therapeutics profitable or losing money?

As of the last Heron Therapeutics earnings report, Heron Therapeutics is currently losing money. Heron Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$13.58 million, a 51.45% decrease year over year.

What was HRTX's earnings growth in the past year?

As of Heron Therapeutics's earnings date in Invalid Date, Heron Therapeutics's earnings has grown year over year. HRTX earnings in the past year totalled -$13.58 million.

What are Heron Therapeutics's earnings expectations?

The current EPS estimate for Heron Therapeutics's earnings report in Invalid Date is -$0.02.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.